All Stories

  1. Case Report: Stevens-Johnson syndrome following a single double dosing of nevirapine-containing regimen once in an HIV-infected woman on long-term antiretroviral therapy.

    Article • F1000Research, June 2015, Faculty of 1000, Ltd.

    Dr Rannakoe J Lehloenya

  2. Faculty Opinions recommendation of Loss from treatment for drug resistant tuberculosis: risk factors and patient outcomes in a community-based program in Khayelitsha, South Africa.

    Article • March 2015, F1000Research

    Dr Rannakoe J Lehloenya

  3. Faculty Opinions recommendation of Mortality among MDR-TB cases: comparison with drug-susceptible tuberculosis and associated factors.

    Article • March 2015, F1000Research

    Dr Rannakoe J Lehloenya

  4. Faculty Opinions recommendation of Adverse drug reactions in dermatology.

    Article • February 2015, F1000Research

    Dr Rannakoe J Lehloenya

  5. Faculty Opinions recommendation of Development and evaluation of a pilot nurse case management model to address multidrug-resistant tuberculosis (MDR-TB) and HIV in South Africa.

    Article • February 2015, F1000Research

    Dr Rannakoe J Lehloenya

  6. Faculty Opinions recommendation of Where should I send it? Optimizing the submission decision process.

    Article • February 2015, F1000Research

    Dr Rannakoe J Lehloenya

  7. Faculty Opinions recommendation of Low resistance to first and second line anti-tuberculosis drugs among treatment naive pulmonary tuberculosis patients in southwestern Uganda.

    Article • February 2015, F1000Research

    Dr Rannakoe J Lehloenya

  8. Faculty Opinions recommendation of Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).

    Article • February 2015, F1000Research

    Dr Rannakoe J Lehloenya

  9. Incidence of anxiety and depression in a predominantly HIV-infected population with severe adverse drug reactions

    Article • Clinical and Translational Allergy, July 2014, Springer Science + Business Media

    Dr Rannakoe J Lehloenya

  10. Factors Associated with Increased Mortality in a Predominantly HIV-Infected Population with Stevens Johnson Syndrome and Toxic Epidermal Necrolysis

    Article • PLoS ONE, April 2014, PLOS

    Dr Rannakoe J Lehloenya

  11. Clinical Presentations of Severe Cutaneous Drug Reactions in HIV-Infected Africans

    Article • Dermatologic Clinics, April 2014, Elsevier

    Dr Rannakoe J Lehloenya

  12. Severe recurrence of drug rash with eosinophilia and systemic symptoms syndrome secondary to rifampicin patch testing in a human immunodeficiency virus-infected man

    Article • Contact Dermatitis, January 2014, Wiley

    Dr Rannakoe J Lehloenya

  13. A Dimorphic Fungus Causing Disseminated Infection in South Africa

    Article • New England Journal of Medicine, October 2013, New England Journal of Medicine (NEJM/MMS)

    Dr Rannakoe J Lehloenya, Dr Michael Louis Locketz

  14. Cutaneous adverse drug reactions caused by FDCAs – we need to characterise and manage them urgently

    Article • South African Medical Journal, September 2013, Health and Medical Publishing Group

    Dr Rannakoe J Lehloenya

  15. Correction: Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa

    Article • PLoS ONE, May 2013, PLOS

    Dr Rannakoe J Lehloenya

  16. Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa

    Article • PLoS ONE, May 2013, PLOS

    Dr Rannakoe J Lehloenya

  17. Aggressive worsening of Sézary syndrome during early antiretroviral therapy

    Article • AIDS, March 2013, Wolters Kluwer Health

    Dr Rannakoe J Lehloenya

  18. Acute generalised exanthematous pustulosis secondary to cotrimoxazole or tenofovir

    Article • Southern African Journal of HIV Medicine, November 2012, Health and Medical Publishing Group

    Dr Rannakoe J Lehloenya

  19. Multiple drug hypersensitivity reactions to anti-tuberculosis drugs: five cases in HIV-infected patients

    Article • The International Journal of Tuberculosis and Lung Disease, September 2012, International Union Against Tuberculosis and Lung Disease

    Dr Rannakoe J Lehloenya

  20. Toxic epidermal necrolysis with failure of re-epithelialization. Could umbilical cord mesenchymal stem cell transplantation have a role?

    Article • Journal of the European Academy of Dermatology and Venereology, August 2012, Wiley

    Dr Rannakoe J Lehloenya

  21. Lichenoid drug reaction to antituberculosis drugs treated through with topical steroids and phototherapy

    Article • Journal of Antimicrobial Chemotherapy, June 2012, Oxford University Press (OUP)

    Dr Rannakoe J Lehloenya

  22. 590 A Case of Chronic Urticaria Complicated by Raoultella Ornithinolytica Urinary Tract Infection, Bronchospasm and Angioedema

    Article • World Allergy Organization Journal, February 2012, Wolters Kluwer Health

    Dr Rannakoe J Lehloenya

  23. Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the art and into the future

    Article • Expert Review of Anti-infective Therapy, January 2012, Taylor & Francis

    Dr Rannakoe J Lehloenya

  24. Outcomes of reintroducing anti-tuberculosis drugs following cutaneous adverse drug reactions

    Article • The International Journal of Tuberculosis and Lung Disease, December 2011, International Union Against Tuberculosis and Lung Disease

    Dr Rannakoe J Lehloenya

  25. Folliculitis keloidalis nuchae is associated with the risk for bleeding from haircuts

    Article • International Journal of Dermatology, September 2011, Wiley

    Dr Rannakoe J Lehloenya

  26. Sweet syndrome: Adverse drug reaction or novel manifestation of HIV-associated immune reconstitution inflammatory syndrome?

    Article • Journal of the American Academy of Dermatology, July 2011, Elsevier

    Dr Rannakoe J Lehloenya

  27. Dermatologic Manifestations of the Immune Reconstitution Inflammatory Syndrome

    Article • Dermatologic Clinics, October 2006, Elsevier

    Dr Rannakoe J Lehloenya